AMI> Vol.5 No.2, April 2015

III. Medical Department of Hematology and Medical Oncology, Technische Universitat München, Munich, Germany
Department of Nuclear Medicine, Technische Universitat München, Munich, Germany
Department of Nuclear Medicine, Universitat Sklinikum Würzburg, Würzburg, Germany
Institute of Pathology—Analytical Pathology, Helmholtz Zentrum München, Neuherberg, Germany
III. Medical Department of Hematology and Medical Oncology, Technische Universitat München, Munich, Germany
Institute of Pathology—Analytical Pathology, Helmholtz Zentrum München, Neuherberg, Germany
German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
Department of Nuclear Medicine, Universitat Sklinikum Würzburg, Würzburg, Germany
III. Medical Department of Hematology and Medical Oncology, Technische Universitat München, Munich, Germany
German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

 

Copyright © 2015 Nicolas Graf, Zhoulei Li, Ken Herrmann, Michaela Aichler, Jolanta Slawska, Axel Walch, Christian Peschel, Markus Schwaiger, Andreas K. Buck, Tobias Dechow, Ulrich Keller et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article

---

Graf, N. , Li, Z. , Herrmann, K. , Aichler, M. , Slawska, J. , Walch, A. , Peschel, C. , Schwaiger, M. , Buck, A. , Dechow, T. and Keller, U. (2015) Preclinical Evaluation of CD40-Directed Immunotherapy in B-Cell Lymphoma Using [¹⁸F]Fluorothymidine-PET. Advances in Molecular Imaging, 5, 17-28. doi: 10.4236/ami.2015.52002.

 

Download citation as EndNote